A single study highlighted that exo-miRNA-26a, containing muscle surface peptides, attenuated cardiac fibrosis and improved cardiac function through mediating forkhead box O1 (FOXO1) downregulation in chronic kidney disease (CKD) mice. The gene discussed is FOXO1; the disease is chronic kidney disease.